ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: FR-OR048

Mesencephalic Astrocyte-Derived Neurotrophic Factor Orchestrates Endoplasmic Reticulum (ER)-Mitochondrial Calcium Homeostasis in Genetic CKD

Session Information

Category: Genetic Diseases of the Kidneys

  • 1201 Genetic Diseases of the Kidneys: Monogenic Kidney Diseases

Authors

  • Fang, Yili, Washington University in St Louis, St. Louis, Missouri, United States
  • Li, Chuang, Washington University in St Louis, St. Louis, Missouri, United States
  • Gu, Chenjian, Washington University in St Louis, St. Louis, Missouri, United States
  • Kidd, Kendrah O., Wake Forest University, Winston-Salem, North Carolina, United States
  • Puri, Anuradhika, Washington University in St Louis, St. Louis, Missouri, United States
  • Jackrel, Meredith, Washington University in St Louis, St. Louis, Missouri, United States
  • Urano, Fumihiko, Washington University in St Louis, St. Louis, Missouri, United States
  • Bleyer, Anthony J., Wake Forest University, Winston-Salem, North Carolina, United States
  • Lindahl, Maria, Helsingin yliopisto, Helsinki, Uusimaa, Finland
  • Chen, Ying Maggie, Washington University in St Louis, St. Louis, Missouri, United States
Background

Autosomal dominant tubulointerstitial kidney disease due to uromodulin mutations (ADTKD-UMOD), a leading hereditary nephropathy and monogenic chronic kidney disease, has no targeted therapies. UMOD is expressed in the thick ascending limb (TAL) tubules and mutant UMOD is retained in the endoplasmic reticulum (ER). Mesencephalic astrocyte-derived neurotrophic factor (MANF) is a novel ER resident chaperone, and its biological role in ADTKD remains to be elucidated.

Methods

The first Umod deletion mutation mouse model, resembling ADTKD patients harboring the most prevalent H177-R185 del mutation, was generated by CRISPR. Meanwhile, stable HEK293 cells expressing WT or the mutant UMOD were established. Patient-derived ADTKD and WT organoids were differentiated from human induced pluripotent stem cells. To investigate the role of MANF in ADTKD, TAL-specific MANF knockout mice were generated, and shRNA was used to knockdown MANF in vitro. ER calcium depletion was assessed by a novel secreted ER calcium-monitoring protein (SERCaMP), and mitochondrial calcium load was determined by confocal live cell imaging of Rhod-2AM. In addition, mitochondrial respiratory function was evaluated by OROBOROS in isolated TALs and Seahorse assays in vitro.

Results

MANF is induced in the mutant TALs carrying the Umod deletion mutation, isolated from the ADTKD mice and kidney organoids. MANF depletion in the mutant TALs further inhibits phosphorylation of AMP-activated protein kinase (AMPK), resulting in exacerbated failure of mitochondrial biogenesis and mitophagy, both in vivo and in vitro. Mechanistically, for the first time, we demonstrate that MANF deficiency in the mutant TALs enhances ER calcium leak and subsequent mitochondrial calcium overload, leading to augmented p-AMPK suppression. Consequently, loss of MANF in the mutant TALs activates mitochondrial DNA leak-induced STING (stimulator of interferon genes) immune response, accelerating renal fibrosis in ADTKD.

Conclusion

We provide the first evidence that MANF regulates ER-mitochondrial calcium transfer, which is essential to maintain mitochondrial health in ADTKD. Our discovery paves the way for potential therapeutic strategies targeting MANF and ER-mitochondria crosstalk in ADTKD.

Funding

  • NIDDK Support

Digital Object Identifier (DOI)